Literature DB >> 2580909

Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). VI. T cell fine specificity.

D R Milich, D L Peterson, G G Leroux-Roels, R A Lerner, F V Chisari.   

Abstract

In the companion paper it was demonstrated that the T cell proliferative response to HBsAg was controlled by I region genes as was previously shown for in vivo anti-HBs production. In this paper, the structural requirements for T cell recognition of HBsAg were compared with B cell (antibody) recognition of HBsAg. Secondly, we attempted to map determinants on HBsAg required for activation of HBsAg-primed T cells, and we examined the influence of I region genotype on the observed T cell antigenic fine specificity. The results of these studies indicate clear differences between T cell and B cell recognition of HBsAg. T cell activation required significantly less native structure as compared with antibody binding to HBsAg. Reduced and alkylated HBsAg, the subunit polypeptide P25, tryptic fragments of P25, and synthetic peptide analogues of HBsAg were all capable of eliciting a T cell proliferative response, whereas these "denatured" forms of the antigen bind anti-HBs marginally or not at all. Furthermore, the results suggest that T cell recognition sites on HBsAg do not necessarily overlap with B cell recognition sites. Examination of T cell fine specificity in a series of H-2 congenic strains, with the use of HBsAg, P25, tryptic fragments of P25, and synthetic peptides, revealed multiple T cell recognition sites on HBsAg, and the particular site(s) recognized is dependent on the H-2 genotype of the responding strain. Finally, preliminary results indicate that the specificity of human, HBsAg-primed T cells appear to be variable among individuals.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2580909

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Characterization of the T cell recognition of hepatitis B surface antigen (HBsAg) by good and poor responders to hepatitis B vaccines.

Authors:  I Desombere; Y Gijbels; A Verwulgen; G Leroux-Roels
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

2.  Immunity to hepatitis B: analysis of antibody and cellular responses in recipients of a plasma-derived vaccine using synthetic peptides mimicking S and pre-S regions.

Authors:  M W Steward; B M Sisley; C Stanley; S E Brown; C R Howard
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

3.  Presentation of an immunodominant T-cell epitope of hepatitis B surface antigen by the HLA-DPw4 molecule.

Authors:  E Celis; R W Karr
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

4.  Mapping an antibody-binding site and a T-cell-stimulating site on the 1A protein of respiratory syncytial virus.

Authors:  J A Nicholas; M A Mitchell; M E Levely; K L Rubino; J H Kinner; N K Harn; C W Smith
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

5.  Normal HBsAg presentation and T-cell defect in the immune response of nonresponders.

Authors:  M Salazar; H Deulofeut; C Granja; R Deulofeut; D E Yunis; D Marcus-Bagley; Z Awdeh; C A Alper; E J Yunis
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

6.  Autopresentation of hepatitis B virus envelope antigens by T cells.

Authors:  C Ferrari; M Pilli; A Penna; A Bertoletti; A Valli; A Cavalli; G Pasetti; F Fiaccadori
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

7.  Analysis of T- and B-cell epitopes of capsid protein of rubella virus by using synthetic peptides.

Authors:  D Ou; P Chong; B Tripet; S Gillam
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

8.  Helper T cells induced by a purified 28-kilodalton antigen of Schistosoma mansoni protect rats against infection.

Authors:  C Auriault; J M Balloul; R J Pierce; M Damonneville; P Sondermeijer; A Capron
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

9.  In vitro immune responses to hepatitis B surface antigen (Pre-S2 and S) following remote infection by hepatitis B virus in humans.

Authors:  T R Cupps; J H Hoofnagle; R W Ellis; W J Miller; L Seeff; A Guerrera; J L Gerin; S A Haas-Smith
Journal:  J Clin Immunol       Date:  1989-05       Impact factor: 8.317

10.  The preS1 antigen of hepatitis B virus is highly immunogenic at the T cell level in man.

Authors:  C Ferrari; A Penna; A Bertoletti; A Cavalli; A Valli; C Schianchi; F Fiaccadori
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.